Evidence map›Paper›PMID 25994406›Full record

ArticleBMC microbiology2015

New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formation by a human wound-associated strain.

Arianna Pompilio, Serena De Nicola, Valentina Crocetta, Simone Guarnieri, Vincenzo Savini, Edoardo Carretto, Giovanni Di Bonaventura

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Pathogens (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Frontiers in bioengineering and biotechnology · 2025
    Article
  6. Article
  7. Investigation on biofilm composition and virulence traits of S. pseudintermedius isolated from infected and colonized dogs.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  8. Isolation ofMicroorganisms · 2024
    Article
  9. Review
  10. Antimicrobial activity of α-mangostin againstFrontiers in cellular and infection microbiology · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Antibiotic Resistance Profile and Biofilm Production ofPharmaceuticals (Basel, Switzerland) · 2021
    Article
  16. BMJ case reports · 2021
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Arianna PompilioDepartment of Medical, Oral, and Biotechnological Sciences, "G. d'Annunzio" University, Via Vestini 31, Chieti, 66100, Italy. ariannapompilio@yahoo.it.
Serena De NicolaDepartment of Medical, Oral, and Biotechnological Sciences, "G. d'Annunzio" University, Via Vestini 31, Chieti, 66100, Italy. serenadenicola@gmail.com.
Valentina CrocettaDepartment of Medical, Oral, and Biotechnological Sciences, "G. d'Annunzio" University, Via Vestini 31, Chieti, 66100, Italy. vale.crocetta@tiscali.it.
Simone GuarnieriCenter for Research on Ageing, "G. d'Annunzio" University Foundation, Chieti, Italy. guarnie@unich.it.
Vincenzo SaviniClinical Microbiology and Virology, "Spirito Santo" Hospital, Pescara, Italy. vsavini2013@gmail.com.
Edoardo CarrettoIRCCS Arcispedale, "Santa Maria Nuova", Reggio Emilia, Italy. edoardo.carretto@asmn.re.it.
Giovanni Di BonaventuraDepartment of Medical, Oral, and Biotechnological Sciences, "G. d'Annunzio" University, Via Vestini 31, Chieti, 66100, Italy. gdibonaventura@unich.it.
University of Chieti-Pescara · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITOspedale di Santo Spirito · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStaphylococcus pseudintermedius is an opportunistic pathogen recognized as the leading cause of skin, ear, and post-operative bacterial infections in dogs and cats. Zoonotic infections have also recently been reported causing endocarditis, infection of surgical wounds, rhinosinusitis, and catheter-related bacteremia. The aim of the present study is to evaluate, for the first time, the pathogenic potential of S. pseudintermedius isolated from a human infection. To this end, strain DSM 25713, which was recently isolated from a wound of a leukemic patient who underwent a bone marrow transplantation, was investigated for biofilm formation and antibiotic-resistance under conditions relevant for wound infection.

resultsThe effect of pH (5.5, 7.1, and 8.7) and the presence of serum (diluted at 1:2, 1:10, and 1:100) on biofilm formation was assessed through a crystal violet assay. The presence of serum significantly reduced the ability to form biofilm, regardless of the pH value tested. In vitro activity of eight antibiotics against biofilm formation and mature 48 h-old biofilms was comparatively assessed by crystal violet assay and viable cell count, respectively. Antibiotics at sub-inhibitory concentrations reduced biofilm formation in a dose-dependent manner, although cefoxitin was the most active, causing a significant reduction already at 1/8xMIC. Rifampicin showed the highest activity against preformed biofilms (MBEC90: 2xMIC). None of the antibiotics completely eradicated the preformed biofilms, regardless of tested concentrations. Confocal and electron microscopy analyses of mature biofilm revealed a complex "mushroom-like" architecture consisting of microcolonies embedded in a fibrillar extracellular matrix.

conclusionsFor the first time, our results show that human wound-associated S. pseudintermedius is able to form inherently antibiotic-resistant biofilms, suggestive of its pathogenic potential, and consistent with recent reports of zoonotic infections.

Indexed as

Anti-Bacterial AgentsBiofilmsCefoxitinDrug Resistance, Multiple, BacterialHumansHydrogen-Ion ConcentrationRifampinStaphylococcal InfectionsStaphylococcusSurgical Wound InfectionAnti-Bacterial AgentsCefoxitinRifampin

Identifiers

PMID25994406
PMCPMC4440327
OpenAlexW1600919011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.